Summary
The effect of cimetidine treatment on the pharmacokinetics and pharmacodynamics of single doses of trimazosin was studied in 6 normotensive volunteers. Co-administration of cimetidine did not significantly affect the overall magnitude of the hypotensive effect of trimazosin. However, the time profile of the blood pressure response was significantly modified particularly with attenuation of the delayed component. Co-administration of cimetidine did not alter alpha1-adrenoceptor antagonism by trimazosin.
There was no significant change in the clearnace and volume of distribution of trimazosin but there was a significant reduction in the area under the concentration-time curve for the metabolite, 1-hydroxytrimazosin.
The reduction in the AUC of 1-hydroxy-trimazosin corresponds in time with the attenuation of the delayed hypotensive response. This is consistent with the suggestion that the delayed hypotensive response is related to an active metabolite, probably 1-hydroxytrimazosin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Daneshmend TK, Roberts CJC (1981) Cimetidine and bioavailability of labetalol. Lancet 1: 565
Donovan MA, Heagerty AM, Patel L, Castleden M, Pohl JE (1981) Cimetidine and bioavailability of propranolol. Lancet 1: 164
Elliott HL, Vincent J, Hughes DMA, Meredith PA, Reid JL (1984) Trimazosin in normotensive subjects. Clin Pharm Ther 35: 156–160
Feeley J, Wilkinson GR, Wood AJJ (1981) Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med 304: 692–695
Feeley J, Robertson D, Island D, Wood JJA (1982) Cimetidine alters plasma catecholamine levels and cortisol and aldosterone excretion. N Engl J Med 306: 1054
Heagerty AM, Donovan MA, Castleden CM, Pohl JF, Patel L, Hedges A (1981) Influence of cimetidine on pharmacokinetics of propranolol. Br Med J 282: 1917–1919
Hughes MA, Meredith PA, Elliott HL (1984) The determination of trimazosin and its metabolite (CP23445) in whole blood by high pressure liquid chromatography using fluorescence detection. J Pharmacol Methods 12: [1]: 29–35
Kirch W, Kohler H, Spahn H, Mutschler E (1981) Interaction of cimetidine with metoprolol, propranolol or atenolol. Lancet 2: 531
Meredith PA, Kelman AW, Elliott HL, Reid JL (1983) Pharmacokinetic and pharmacodynamic modelling of trimazosin and its major metabolite. J Pharmacokinet Biopharm 11 [4] 323–335
Ochs HR, Greenblatt DJ, Gugler R, Mustefering A, Loeniskar A, Abernethy DR (1983) Cimetidine impairs nitrazepam clearance. Clin Pharmacol Ther 34: 227–230
Reinmann IW, Klotz U, Siems B, Froheh JC (1981) Cimetidine increases steady state plasma levels of propranolol. Br J Clin Pharmacol 12: 785–790
Saltissi S, Crowther A, Byrne C, Coltart DJ (1981) The effects of chronic oral cimetidine therapy on the cardiovascular system in man. Br J Clin Pharmacol 11: 497–503
Singleton W, Saxton CAPD, Hernandez R (1980) Alphablocking effect of prazosin, trimazosin and UK 33274 in man. In: Turner P, Paugham C (eds) World Conference on Clinical Pharmacology and Therapeutics (abstracts). Macindlass, London, Basingstoke
Singleton W, Saxton CAPD, Hernandez J, Prichard BNC (1982) Post-junctional selectivity of alpha-blockade with prazosin, trimazosin and UK 33274 in man. J Cardiovasc Pharmacol 4: [Suppl 1] 145–151
Somogyi A, Gugler R (1982) Drug interactions with cimetidine. Clin Pharmacokinet 7: 23–41
Somogyi A, McLean A, Heinzow B (1983) Cimetidine-procainamide pharmacokinetic interaction in man: Evidence of competition for tubular secretion of basic drugs. Eur J Clin Pharmacol 25: 339–345
Sonne J, Paulsen HE, Dossing M, Larsen NE, Andreasen PB (1981) Cimetidine clearance and bioavailability in hepatic cirrhosis. Clin Pharmacol Ther 29: 191–192
Starke K, Endo T, Taube HD (1975) Relative pre and post synaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedebergs Arch Pharmacol 55–78
Sumner DJ, Elliott HL, Reid JL (1982) Analysis of the pressor dose response. Clin Pharm Ther 32 [4]: 450–458
Warburton S, Opie LH, Kennelly BM, Miller GO (1979) Does cimetidine alter the cardiac response to exercise and propranolol. S. Afr Med J 55: [27] 1125–1127
Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–390
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vincent, J., Elliott, H.L., Meredith, P.A. et al. The effect of cimetidine on the pharmacokinetics, pharmacodynamics and alpha1-adrenoceptor responsiveness of trimazosin in man. Eur J Clin Pharmacol 29, 301–306 (1985). https://doi.org/10.1007/BF00544084
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544084